scispace - formally typeset
Search or ask a question
Author

Alessandro Dolmella

Bio: Alessandro Dolmella is an academic researcher from University of Padua. The author has contributed to research in topics: Ligand & Denticity. The author has an hindex of 27, co-authored 116 publications receiving 2284 citations.


Papers
More filters
Journal ArticleDOI
TL;DR: In this article, the ligating ability of 1,1′-bis(diphenylphosphino) ferrocene is discussed. But the focus is on the extensive coordination chemistry exhibited by this ligand to transition metals.

205 citations

Journal ArticleDOI
TL;DR: In this article, a review of reported crystal data of six-coordinated Ga(III) complexes is presented to gain information to be used in the design of novel Ga complexes of medicinal interest.

95 citations

Journal ArticleDOI
TL;DR: The extensive use of NMR spectroscopy and isotope effects, with the support of mass spectrometry, electrochemistry, and single crystal X-ray crystallography, led us to confirm that noble metals indeed dope the cluster at its central position, whereas no matter how the doping reaction is conducted and the nature of the ligand, the position of both Cd and Hg is always on the icosahedron shell, rather than at the central or staple position.
Abstract: The study of the structures and properties of atomically precise gold nanoclusters is the object of active research worldwide. Recently, research has been also focusing on the doping of metal nanoclusters through introduction of noble metals, such as platinum, and less noble metals, such as cadmium and mercury. Previous studies, which relied extensively on the use of mass spectrometry and single-crystal X-ray crystallography, led to the assignment of the location of each of these foreign-metal atoms. Our study provides new insights into this topic and, particularly, compelling evidence about the actual position of the selected metal atoms M = Pt, Pd, Hg, and Cd in the structure of Au24M(SR)180. To make sure that the results were not dependent on the thiolate, for SR we used both butanethiolate and phenylethanethiolate. The clusters were prepared according to different literature procedures that were supposed to lead to different doping positions. Use of NMR spectroscopy and isotope effects, with the support of mass spectrometry, electrochemistry, and single-crystal X-ray crystallography, led us to confirm that noble metals indeed dope the cluster at its central position, whereas no matter how the doping reaction is conducted and the nature of the ligand, the position of both Cd and Hg is always on the icosahedron shell, rather than at the central or staple position, as often reported. Our results not only provide a reassessment of previous conclusions, but also highlight the importance of NMR spectroscopy studies and cast doubts on drawing conclusions mostly based on single-crystal X-ray crystallography.

95 citations

Journal ArticleDOI
TL;DR: The antitumor efficacy of complex 1 was validated in the murine Lewis Lung Carcinoma (LLC) model and morphology studies revealed an extensive cytoplasmic vacuolization coherently with a paraptosis-like cell death mechanism.
Abstract: Tetrahedral copper(I) TpCuP complexes 1-15, where Tp is a N,N,N-tris(azolyl)borate and P is a tertiary phosphine, have been synthesized and characterized by means of NMR, ESI-MS, and XAS-EXAFS, and X-ray diffraction analyses on the representative complexes 1 and 10, respectively. All copper(I) complexes were evaluated for their antiproliferative activity against a panel of human cancer cell lines (including cisplatin and multidrug-resistant sublines). The two most effective complexes [HB(pz)3]Cu(PCN), 1, and [HB(pz)3]Cu(PTA), 2, showed selectivity toward tumor vs normal cells, inhibition of 26S proteasome activity associated with endoplasmic reticulum (ER) stress, and unfolded protein response (UPR) activation. No biochemical hallmarks of apoptosis were detected, and morphology studies revealed an extensive cytoplasmic vacuolization coherently with a paraptosis-like cell death mechanism. Finally, the antitumor efficacy of complex 1 was validated in the murine Lewis Lung Carcinoma (LLC) model.

94 citations

Journal ArticleDOI
TL;DR: In this paper, the first synthesis of the corrole ring by self-condensation of a monopyrrolic unit is reported, and the reaction occurs only in the presence of cobalt ions; it leads to the formation of (triphenylphosphine)(5,10,15-triphensyl-2,3,7,8,12, 13,17,18-octamethylcorrolato)cobalt(III), [Co(OMTPC)PPh3] and represents the first example of interconversion between a p
Abstract: The first synthesis of the corrole ring by self-condensation of a monopyrrolic unit is reported. The reaction occurs only in the presence of cobalt ions; it leads to the formation of (triphenylphosphine)(5,10,15-triphenyl-2,3,7,8,12, 13,17,18-octamethylcorrolato)cobalt(III), [Co(OMTPC)PPh3] and represents the first example of interconversion between a porphyrinoid and a corrole structure. Crystals of [Co(OMTPC)PPh3].CH2Cl2 have been obtained by slow diffusion of methanol into a dichloromethane solution of the complex and have been characterized by single-crystal X-ray analysis. They crystallize in the triclinic system, space group P1BAR, with a = 10.628 (2) angstrom, b = 11.585(2) angstrom, c = 22.352(4) angstrom, alpha = 84.93(2)-degrees, beta = 78.56(2)-degrees, gamma = 72.93(2)-degrees, and Z = 2. The structure was solved by heavy-atom methods and refined by least-square techniques to R = 0.051 for 6377 unique data [F(o) > 4 sigma(F(o))]. The analysis reveals the substantial planarity of the macrocyclic ring. In the 23-atom core of the corrole moiety each atom shows an average displacement from the plane of best fit of 0.14 angstrom, with the largest deviations being +0.33 and -0.33 angstrom for C(2) and C(12), respectively. The synthesis of diphenyl derivatives of corrole: (triphenylphosphine) (5,10-diphenyl-2,3,7,8,12,13,17,18-octamethylcorrolato)cobalt(III), [Co(5,10-OMDPC)PPh3], and (triphenylphosphine) (5,15-diphenyl-2,3,7,8,12,13,17,18-octamethylcorrolato)cobalt(III), [Co(5,15-OMDPC)PPh3], is also reported. Plausible reaction pathways leading to the formation of the two isomers are discussed together with the spectral properties of the complexes.

83 citations


Cited by
More filters
Journal ArticleDOI
TL;DR: This work presents a meta-analysis of multi-NHCs Linked by Spacers and its applications in Catalysis and Nanomaterials, which shows clear trends in both the number and complexity of the components and their applications.
Abstract: 2.3.5. Multi-NHCs Linked by Spacers 3568 2.4. The Ag2O Route 3570 2.4.1. Feasibility 3570 2.4.2. Complications 3571 2.4.3. Theoretical Consideration 3572 2.5. Applications 3572 2.5.1. Ag(I)-NHCs in NHC Transfer 3572 2.5.2. Ag(I)-NHCs in Catalysis 3572 2.5.3. Ag(I)-NHCs in Medicine 3572 2.5.4. Ag(I)-NHCs in Nanomaterials 3573 3. Au(I)and Au(III)-NHCs 3573 3.1. Historical Background 3573 3.2. General Synthetic Methods 3573 3.3. Formation of Au(I)and Au(III)-NHCs 3574 3.3.1. Neutral [Au(NHC)L] 3574 3.3.2. Ionic [Au(NHC)L][Anion] 3576 3.3.3. Multinuclear Au(I)-NHCs 3578 3.3.4. Other Classes of Au(I)-NHCs 3578 3.3.5. Au(III)-NHC Complexes 3579 3.4. Applications 3579 3.4.1. Au(I)and Au(III)-NHCs in Catalysis 3579 3.4.2. Au(I)-NHCs in Medicine 3580 4. Cu(I)and Cu(II)-NHCs 3581 4.1. Historical Background 3581 4.2. General Synthetic Methods 3582 4.3. Formation of Cu(I)and Cu(II)-NHCs 3583 4.3.1. Complexes Containing the Cu(NHC)2 Core 3583 4.3.2. [Cu(NHC)(Halide)] 3583 4.3.3. [Cu(NHC)(Ligand)] 3584 4.3.4. Multinuclear Cu(I)and Cu(II)-NHCs 3589 4.4. Catalysis 3591 4.4.1. Past Events 3591 4.4.2. Recent Advancements 3591 5. Photoluminescence 3592 6. Conclusions 3594 7. Abbreviations 3594 8. Acknowledgments 3595 9. References 3595

906 citations

Journal ArticleDOI
TL;DR: SPECT and PET technology has been around for decades, but its use remained limited because of the limited availability of relevant isotopes which had to be produced in nuclear reactors or particle accelerators, but the introduction of the small biomedical cyclotron, the self-contained radionuclide generator and the dedicated small animal or clinical SPECT andPET scanners to hospitals and research facilities has increased the demand for SPect and PET isotopes.
Abstract: Molecular imaging is the visualization, characterization and measurement of biological processes at the molecular and cellular levels in humans and other living systems. Molecular imaging agents are probes used to visualize, characterize and measure biological processes in living systems. These two definitions were put forth by the Sociey of Nuclear Medicine (SNM) in 2007 as a way to capture the interdisciplinary nature of this relatively new field. The emergence of molecular imaging as a scientific discipline is a result of advances in chemistry, biology, physics and engineering, and the application of imaging probes and technologies has reshaped the philosophy of drug discovery in the pharmaceutical sciences by providing more cost effective ways to evaluate the efficacy of a drug candidate and allowing pharmaceutical companies to reduce the time it takes to introduce new therapeutics to the marketplace. Finally the impact of molecular imaging on clinical medicine has been extensive since it allows a physician to diagnose a patient’s illness, prescribe treatment and monitor the efficacy of that treatment non-invasively. Single Photon Emission Computed Tomography (SPECT) and Positron Emission Tomography (PET) were the first molecular imaging modalities used clinically. SPECT requires the use of a contrast agent labeled with a gamma emitting radionuclide, which should have an ideal gamma energy of 100-250 keV. These gamma rays are recorded by the detectors of a dedicated gamma camera or SPECT instrument and after signal processing can be converted into an image indentifying the localization of the radiotracer. PET requires the injected radiopharmaceutical to be labeled with a positron emitting radionuclide. As the radionuclide decays it ejects a positron from its nucleus which travels a short distance before being annihilated with an electron to release two 511 keV gamma rays 180° apart that are detected by the PET scanner (Figure 1). After sufficient acquisition time the data are reconstructed using computer based algorithms to yield images of the radiotracer’s location within the organism. When compared to SPECT, PET has greater advantages with respect to sensitivity and resolution and has been gaining in clinical popularity, with the number of PET-based studies expected to reach 3.2 million by 2010.1 While SPECT and PET technology has been around for decades, its use remained limited because of the limited availability of relevant isotopes which had to be produced in nuclear reactors or particle accelerators. However, the introduction of the small biomedical cyclotron, the self-contained radionuclide generator and the dedicated small animal or clinical SPECT and PET scanners to hospitals and research facilities has increased the demand for SPECT and PET isotopes. Figure 1 Cartoon depicting the fundamental principle of Positron Emission Tomography (PET). As the targeting group interacts with the cell surface receptor, the positron emitting radio-metal decays by ejecting β+ particles from its nucleus. After traveling ... Traditional PET isotopes such as 18F, 15O, 13N and 11C have been developed for incorporation into small molecules, but due to their often lengthy radio-syntheses, short half-lives and rapid clearance, only early time points were available for imaging, leaving the investigation of biological processes, which occur over the duration of hours or days, difficult to explore. With the continuing development of biological targeting agents such as proteins, peptides, antibodies and nanoparticles, which demonstrate a range of biological half-lives, a need arose to produce new radionuclides with half-lives complementary with their biological properties. As a result, the production and radiochemistry of radiometals such as Zr, Y, In, Ga and Cu have been investigated as radionuclide labels for biomolecules since they have the potential to combine their favorable decay characteristics with the biological characteristics of the targeting molecule to become a useful radiopharmaceutical (Tables ​(Tables11 and ​and22).2 Table 1 Gamma- and Beta-Emitting Radiometals Table 2 Positron-Emitting Radiometals The number of papers published describing the production or use of these radiometals continues to expand rapidly, and in recognition of this fact, the authors have attempted to present a comprehensive review of this literature as it relates to the production, ligand development and radiopharmaceutical applications of radiometals (excluding 99mTc) since 1999. While numerous reviews have appeared describing certain aspects of the production, coordination chemistry or application of these radiometals,2-18 very few exhaustive reviews have been published.10,12 Additionally, this review has been written to be used as an individual resource or as a companion resource to the review written by Anderson and Welch in 1999.12 Together, they provide a literature survey spanning 50 years of scientific discovery. To accomplish this goal, this review has been organized into three sections: the first section discusses the coordination chemistry of the metal ions Zr, Y, In, Ga and Cu and their chelators in the context of radiopharmaceutical development; the second section describes the methods used to produce Zr, Y, In, Ga and Cu radioisotopes; and the final section describes the application of these radiometals in diagnostic imaging and radiotherapy.

768 citations

Journal ArticleDOI
TL;DR: The Cr(III)-based ethylene oligomerization precatalysts that incorporate a CNC-pincer carbene ligand were tested for polymerization of ethylene with a MAO cocatalyst, showing low activities and a broad weight distribution of the polymers.
Abstract: ion of the chloride ligands, compound 2 was further reacted with MeMgCl, yielding the bimetallic compound 3 in which the biscarbene ligand is bridging two Cr(II) atoms, also bridged by two methyl ligands. Recent studies by Arnold and co-workers showed that the incorporation of an anionic functional group (alkoxide, amido, or amino) in an NHC unit allows the preparation of tridentate ligands capable of coordinating to d0 early transition metals such as yttrium, titanium, and zirconium.87 The lithium aminodicarbene chloride complex 5 reacts with Y[N(SiMe3)2]3 affording the yttrium(III) complex 6 (Scheme 10). Hexacoordinated titanium (7) and zirconium (8) complexes were synthesized by reaction of 4 with M(NEt2)4 (M ) Ti, Zr) (Scheme 10). Complexes 7 and 8 constituted the first examples of group 3 and 4 metal complexes with monoanionic biscarbene ligands. Another interesting example of early transition metal NHC-based complexes was described by Smith and coworkers.88 By the reaction shown in Scheme 11, the tris(NHC)borate 989,90 afforded a tricarbonyl complex of Mn(I) with a tripodal tris-NHC ligand, 10. The analysis of the ν(CO) bands on the IR spectrum of this complex showed that 9 is the most electron-donating tripodal ligand compared with all others that have been bound to the same Mntricarbonyl fragment. Compound 10 is air-sensitive and is easily oxidized to a homoleptic Mn(IV) complex (11, Scheme 11), which is the first example of a Mn(IV)-NHC complex reported to-date. 4.2. Catalytic Applications Although many catalytic applications of late transition metal complexes bearing poly-NHC ligands have been described, those of early transition metals are restricted to a few examples. In 2003, Gibson and co-workers reported Cr(III)-based ethylene oligomerization precatalysts that incorporate a CNC-pincer carbene ligand.91,92 More recently, McGuinness shed some light on the mechanism of the reaction with the mentioned pincer complexes in combination with MAO.93 The Cr(II) and Cr(III) complexes described by Theopold were tested for polymerization of ethylene with a MAO cocatalyst, showing low activities and a broad weight distribution of the polymers.85 In particular, Cr(II) compounds such as 2 (Scheme 9) were unreactive to ethylene when exposed to MAO, showing that the more Lewis acidic Cr(III) performs better in this reaction. The authors pointed out the ease with which the Cr(III) complexes are reduced to Cr(II), arguing that very strong σ-donating but soft NHC ligands may have a stronger affinity for the softer Cr(II) rather than the harder Cr(III). Thus, they concluded that this ligand system may be better suited for lower oxidation state chromium chemistry and that, due to the inactivity of the Cr(II) compounds tested, it would not lead to successful results in ethylene polymerization. 5. Poly-NHC Ligands in Complexes of Group 8 Metals

763 citations